Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

News SummaryMost relevantAll newsSector newsTweets 
Latest news on ALLERGAN, INC.
04/19 ALLERGAN : Novartis expands development programs for NASH through clinical colla..
04/18 ALLERGAN PLC (NYSE : AGN) Files An 8-K Other Events
04/18 ALLERGAN PLC : Other Events (form 8-K)
04/14 ALLERGAN : Exclusive New Interview Released with Allergan Global Regulatory Affa..
04/13 ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
04/12 ALLERGAN : New Interview Released with Allergan Global Regulatory Affairs Direct..
04/12 ALLERGAN PLC ORDINARY SHARES’ : AGN) Initiative Creating Awareness to Peo..
04/12 ALLERGAN : Introducing Juvederm Vollure® at The Choe Center
04/12 Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
04/11 ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
04/08 ALLERGAN : After iffy phase 2, Allergan plows forward with phase 3 Botox depress..
04/07 ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
04/07 ALLERGAN : acquires Zeltiq
04/07 ALLERGAN : To Test Botox For Depression Despite Mixed Results
04/06 IMPAX LABORATORIES : Board of Directors Appoints Paul M. Bisaro President and CE..
04/05 ALLERGAN : Center for Facial Rejuvenation's Cindy Wilson, NP Chosen as Official ..
04/05 ALLERGAN : exec Sanjiv Patel becomes new CEO at upstart Relay
04/02 ALLERGAN : Dr. Rubinstein Receives Allergan "Top 500" Award
03/30 ALLERGAN : FDA Approves Juvéderm Vollure XC for Laugh Lines, Notes Dr. F. Victor..
03/29 ALLERGAN : Dr. Justin Harper Selected for Allergans Facial Aesthetics National A..
03/29 ALLERGAN : Paratek hit late-stage acne goals, prep for sarecycline NDA
03/28 ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
03/28 ALLERGAN : Paratek Announce Positive Results from Two Phase 3 Trials for Moderat..
03/28 ALLERGAN : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National ..
03/27 ALLERGAN : and Paratek Show Positive Results For Acne Treatment
03/27 PARATEK PHARMACEUTICALS, INC. (NASDA : PRTK) Files An 8-K Regulation FD Disclosu..
03/27 ALLERGAN : What Are Inversion Deals?
03/24 GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
03/24 GLOBAL GASTROINTESTINAL DRUGS MARKET : Abbott Laboratories, Allergan, AstraZenec..
03/22 Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
03/22 ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
03/20 ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
03/17 ALLERGAN : Prevent Blindness and Allergan Work Together Through See America to P..
03/17 ALLERGAN : Editas partner on CRISPR tech in eye diseases
03/17 ALLERGAN : Lupin in fast lane with 5 launches in 15 days
03/16 ALLERGAN : Prevent Blindness and Allergan Work Together Through 'See America' to..
03/16 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella for Lip Fullness And ..
03/16 ALLERGAN : celebrates commitment to KSA with new entity inaugural
03/15 ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella® for Lip Fullness And..
03/15 EDITAS MEDICINE,INC. (NASDAQ : EDIT) Files An 8-K Entry into a Material Definiti..
03/15 Heptares adds Daiichi pain pact to string of R&D deals
03/15 ALLERGAN : Blindness treatment key to deal
03/14 ALLERGAN : Common explains why he's fighting against a blindness epidemic most p..
03/14 ALLERGAN : New Survey Reveals Impact Of Double Chin On Self-Perception And Behav..
03/13 FOOD AND DRUG ADMINISTRATION ACCEPTS : AGN) Vraylar For Review As A Supplemental..
03/11 ALLERGAN : Saudi LLC celebrates expansion and commitment to KSA
03/10 ALLERGAN : Saudi LLC celebrates expansion and commitment to KSA
03/06 ALLERGAN : El Paso Cosmetic Surgery Is Once Again a Top 50 Account on Allergan's..
03/06 INSIDER TRADING ACTIVITY ALLERGAN PL : AGN) – Director Sold 70,000 shares ..
03/04 ALLERGAN : Botox Firm Allergan to Spend €42m in Irish Expansion
02/27 ALLERGAN : New Eyepowerment™ Campaign Urges The Up To 33 Million Americans..
02/26 INSIDER Q&A : Allergan CEO on impact of limiting price hikes
02/25 ALLERGAN : Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap
02/24 ALLERGAN : Considering Cosmetic Surgery? Try Asking Your Self Worth First
02/22 ALLERGAN : FlexJobs Identifies the Top 10 International Companies for Remote Job..
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/17 Botulinum Toxins Market 2017 - Allergan, Ipsen, Merz, US WorldMeds, Medytox, ..
02/17 ALLERGAN : Health Companies Think Fat-Freezing Is the New Botox
02/14 ADVERUM BIOTECHNOLOGIES, INC. (NASDA : ADVM) Files An 8-K Departure of Directors..
02/14 ALLERGAN, INC. : Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence ..
02/14 ALLERGAN : to buy fat-fighting firm for $2.5bn
02/14 ALLERGAN : Acquires Zeltiq, The Makers of CoolSculpting
02/13 Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
02/13 ZELTIQ AESTHETICS : Allergan to acquire Zeltiq and its 'CoolSculpting System' fo..
02/13 MARKETS RIGHT NOW : US indexes push to new all-time highs
02/13 Stada to hold takeover talks with rival suitors Cinven and Advent
02/13 MARKETS RIGHT NOW : US indexes open at record highs
02/13 ALLERGAN : to spend $2.48 B on CoolSculpting provider Zeltiq
02/13 US indexes open at record highs Monday
02/11 PFIZER : bounces back from Allergan setback by buying, buying, buying
02/11 ALLERGAN : Sara Shikhman Selected for Allergan's Brilliant Distinctions National..
02/09 ALLERGAN : eyes strong growth as it expects no US tax reform in 2017
02/08 Allergan says U.S. tax reform unlikely in 2017, sees strong year
1  2  3  4  5  6  7  8  9  10Next
Income Statement Evolution
More Financials
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON5.69%330 078
ROCHE HOLDING LTD.8.21%217 624
PFIZER INC.3.88%200 330
NOVARTIS AG-1.15%192 857
MERCK & CO., INC.5.13%169 673
More Results